The Peptide Development Platform committed to providing comprehensive, end-to-end services for peptide drug development at all stages, from early research, clinical phases, to commercialization, enabling more efficient and compliant peptide drug development for partners. Focuses on the research, development, and manufacturing services related to peptide drugs, including: ● Development and production of unnatural amino acids, pseudoproline dipeptides, conjugation linkers, peptide intermediates, linear peptides, cyclic peptides, and modified peptides ● Development, transfer, and validation of synthetic processes and analytical methods ● GMP manufacturing, stability studies, and preparation of regulatory submission documents